Patent details

EN | LT

LT - 2-(chinoksalin-5-ilsulfonilamino)-benzamido junginiai kaip CCK2 moduliatoriai

EN - 2-(QUINOXALIN-5-YLSULFONYLAMINO)-BENZAMIDE COMPOUNDS AS CCK2 MODULATORS

Legal status

Patent lapsed (non-payment of fees)

Claims | Abstract | Licences/Sublicenses

Patent application specification | Search report | Patent specification (5.30 Mb)

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.: (2006.01)	C07D 241/00 C07D 401/00 C07D 403/00 C07D 413/00

Patent
(11)	Number of the document	5410
(13)	Kind of document	B
(21)	Application number	2006 017
(22)	Date of filing the application	2006-03-07
(41)	Date of publication of the application	2006-11-27
(45)	Date of publication of patent	2007-03-26

PCT application
(86)	Number	PCT/US2004/025153
	Date	2004-08-04

PCT application publication
(87)	Number	WO2005016896
	Date	2005-02-24

Priority applications
(30)	Number	Date	Country code
	60/494,074	2003-08-08	US

Applicant
(71)	JANSSEN PHARMACEUTICA N. V., Turnhoutsebaan 30, 2340 Beerse, BE

Inventors
(72)	Brett D. ALLISON, US Michael D. HACK, US Victor K. PHUONG, US Michael H. RABINOWITZ, US Mark D. ROSEN, US

Grantee
(73)	JANSSEN PHARMACEUTICA N. V., Turnhoutsebaan 30, 2340 Beerse, BE

Attorney or representative
(74)	Marius JAKULIS - JASON, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT

Title
(54)	2-(QUINOXALIN-5-YLSULFONYLAMINO)-BENZAMIDE COMPOUNDS AS CCK2 MODULATORS

Last renewal fee
	Payment date	Validity (years)	Amount
	2009-07-08	6	480.00 LTL

Legal status
	Patent lapsed (non-payment of fees)
	Invalidation date	2010-08-04